DARLENE M DEPTULA-HICKS
CIK 1089409 · See Remarks · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
6
Total Filings
24
Lifetime Open-Market Net
-$12.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALDX | Director | — | $1.51 | — | $0 | 1 | 2026-06-11 |
| F-star Therapeutics, Inc. (FSTX) Delisted | See Remarks | 25,539 | $7.12 | $181.8K | $0 | 7 | 2023-03-09 |
| XBIO | Director | — | $3.22 | — | $0 | 2 | 2017-06-15 |
| T2 Biosystems, Inc. (TTOO) Delisted | SVP & Chief Financial Officer | 1 | $0.00 | $0 | $14.3K | 2 | 2017-06-08 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | SVP, Chief Financial Officer | 62 | $13.60 | $843 | $8.3K | 2 | 2016-06-15 |
| ICAD INC (ICAD) Delisted | Exec VP of Finance, CFO | 25,011 | $3.87 | $96.8K | -$35.0K | 10 | 2011-03-31 |
Recent Filings · Page 2 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-02 | T2 Biosystems, Inc. (TTOO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-23 | XBIO | Grant (A) | — | $0 | EDGAR |
| 2016-06-15 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Buy (P) | +5,000 | $8.3K | EDGAR |
| 2015-09-03 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-03-31 | ICAD INC (ICAD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-03-04 | ICAD INC (ICAD) Delisted | Tax (F) | −5,108 | -$6.3K | EDGAR |
| 2010-07-21 | ICAD INC (ICAD) Delisted | Tax (F) | −4,408 | -$8.8K | EDGAR |
| 2010-06-03 | ICAD INC (ICAD) Delisted | Tax (F) | −6,613 | -$9.5K | EDGAR |
| 2010-03-11 | ICAD INC (ICAD) Delisted | Sell (S) | −25,000 | -$35.0K | EDGAR |
| 2010-03-03 | ICAD INC (ICAD) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.